세계의 위 염전 치료 시장 보고서(2025년)
Gastric Volvulus Treatment Global Market Report 2025
상품코드 : 1821678
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,632,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,586,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,540,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

위 염전 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에 CAGR은 6.5%를 나타낼 것으로 예측되고 371억 8,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 규제 변화 및 승인, 수술 절차의 혁신, 고령 인구 증가, 맞춤형 치료 계획, 첨단 영상 기술 도입 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 최소 침습 수술 기술, 인식 제고 및 조기 개입, 치료 방식 연구, 협력적 의료 관행, 맞춤형 치료 접근법이 포함됩니다.

향후 5년간 6.5% 성장 전망은 이전 예측 대비 0.2% 소폭 하락한 수치다. 이 하락은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 장벽은 브라질과 중국에서 원하는 복강경 감압 장비 및 비위튜브 비용을 증가시켜 응급 수술 치료를 저해할 것으로 예상됩니다. 이는 생명을 구하는 시술을 지연시키고 일반 외과 비용을 상승시킬 것입니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과가 더욱 광범위하게 나타날 것입니다.

노년 인구 증가는 향후 위 염전 치료 시장 확장을 촉진할 것으로 전망됩니다. 노인 인구는 면역력 저하와 노화로 다양한 질환에 취약한 65세 이상 고령자를 의미합니다. 위 염전은 주로 50세 이상에서 발생합니다. 따라서 노인 인구 증가는 시장을 촉진할 것으로 예상됩니다. 예를 들어, 2024년 1월 미국 비영리 기관인 인구참조국(PRB)의 통계에 따르면, 65세 이상 미국인 인구는 2022년 5,800만 명에서 2050년까지 8,200만 명으로 47% 증가할 것으로 예상됩니다. 또한 전체 인구에서 차지하는 비중은 17%에서 23%로 증가할 전망입니다. 따라서 증가하는 노인 인구는 위 염전 치료 시장의 주요 촉진요인입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Gastric volvulus treatment involves surgical interventions, specifically focusing on volvulus reduction and the reintegration of the stomach into the abdominal cavity, especially in cases of intrathoracic migration. The treatment also addresses the correction of causal factors. Gastric volvulus surgery is typically a straightforward procedure, encompassing de-rotation, lowering of hernial contents into the abdominal wall, and repair of the hernial defect.

The main types of gastric volvulus treatment are organo-axial and mesentero-axial volvulus. Organo-axial volvulus occurs when the abdomen undergoes a 180-degree spin around its long axis, resulting in this condition. Treatment options include medication and surgery, with various routes of administration such as oral and parenteral. Distribution channels for these treatments include hospital pharmacies and retail pharmacies, serving purposes in hospitals, home healthcare, specialty clinics, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The gastric volvulus treatment market research report is one of a series of new reports from. The Business Research Company that provides gastric volvulus treatment market statistics, including gastric volvulus treatment industry global market size, regional shares, competitors with a gastric volvulus treatment market share, detailed gastric volvulus treatment market segments, market trends and opportunities, and any further data you may need to thrive in the gastric volvulus treatment industry. This gastric volvulus treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gastric volvulus treatment market size has grown strongly in recent years. It will grow from $27.36 billion in 2024 to $28.86 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to advancements in surgical techniques, improved diagnostic technologies, awareness and education, rise in minimally invasive procedures, research and clinical studies.

The gastric volvulus treatment market size is expected to see strong growth in the next few years. It will grow to $37.18 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to regulatory changes and approvals, innovations in surgical procedures, growing geriatric population, customized treatment plans, adoption of advanced imaging techniques. Major trends in the forecast period include minimally invasive surgical techniques, awareness and early intervention, research in treatment modalities, collaborative medical practices, and customized treatment approaches.

The forecast of 6.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper emergency surgical care by increasing the cost of laparoscopic reduction instruments and nasogastric tubes sourced from Brazil and China, thereby delaying life-saving interventions and elevating general surgery costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

A growing geriatric population is projected to drive the expansion of the gastric volvulus treatment market in the future. The geriatric population refers to older adults aged 65 and above, who are prone to various diseases due to decreased immunity and aging. Gastric volvulus is primarily seen in individuals over the age of 50. Consequently, the increase in the geriatric population is expected to boost the market. For example, in January 2024, statistics from the Population Reference Bureau (PRB), a US-based nonprofit organization, indicated that the number of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, their share of the total population is projected to grow from 17% to 23%. Therefore, the rising geriatric population is a key driver of the gastric volvulus treatment market.

The rising prevalence of gastrointestinal diseases is anticipated to drive the growth of the gastric volvulus treatment market in the upcoming years. Gastrointestinal diseases refer to medical conditions that affect the internal structures of the gastrointestinal (GI) tract, often referred to as gastrointestinal disorders, including ailments such as gastritis, inflammatory bowel disease, and gastric cancer. The comprehensive care provided during gastric volvulus treatment may encompass strategies and considerations that enhance the overall health of the gastrointestinal system and its related disorders. For example, in September 2022, Cancer Australia, an organization focused on cancer awareness and support for individuals affected by cancer in Australia and its territories, reported that there were an estimated 2,572 new cases of stomach cancer expected to be diagnosed in Australia in 2022 (1,661 males and 911 females). In 2022, the likelihood of developing stomach cancer by age 85 was 1 in 114 (or 0.87%), with the odds being 1 in 1.1 (87%) for men and 1 in 167 (0.60%) for women. Thus, the increasing incidence of gastrointestinal diseases is propelling the gastric volvulus treatment market.

Product innovations emerge as a prominent trend gaining traction in the gastric volvulus treatment market. Major companies in the market are introducing innovative products to maintain their competitive positions. For instance, in October 2023, Pfizer Inc., a pharmaceutical company based in the United States, announced the FDA approval of VELSIPITY (etrasimod) for people with moderate to severe active ulcerative colitis. This once-daily oral sphingosine-1-phosphate (S1P) receptor activator offers a positive benefit-risk profile, providing adults with an effective, steroid-free resolution through a convenient oral pill.

Companies operating in the gastric volvulus treatment market are focusing on product innovations such as digital radiology solutions to enhance radiologists' efficiency. A digital radiology solution involves leveraging digital technology in medical imaging for visualizing internal body structures and aiding in the diagnosis and management of conditions such as gastric volvulus through digital image capture and analysis. For instance, in February 2023, Carestream Health India Pvt. Ltd. launched the DRX Compass, a digital radiological solution designed for accuracy, convenience, and customization. This innovative solution empowers radiologists with heightened productivity and flexibility in configuring the system based on individual requirements.

Key players in the gastric volvulus treatment market are concentrating on developing innovative solutions like advanced hyperbaric oxygen therapy to improve access to cutting-edge medical treatments, thereby enhancing patient outcomes and community health. Advanced hyperbaric oxygen therapy (HBOT) is a medical procedure that involves inhaling 100% oxygen in a pressurized chamber, which enhances oxygen delivery to tissues and promotes healing. This therapy may prove beneficial in the treatment of gastric volvulus by improving tissue oxygenation and aiding recovery from ischemia or surgical procedures. For example, in December 2024, HBOT India, a medical facility in India that specializes in hyperbaric oxygen therapy, introduced Medical Grade 3 ATA Hyperbaric Oxygen Therapy. This treatment enhances healing by increasing oxygen absorption, making it effective for chronic wounds, decompression sickness, and various other conditions. Its launch in Gurgaon significantly broadens access to advanced medical treatments in the area, thereby supporting the health and well-being of the community.

Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gastric volvulus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastric volvulus treatment market includes revenues earned by entities that perform laparotomy, gastric detorsion, and gastric fixation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gastric Volvulus Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gastric volvulus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for gastric volvulus treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric volvulus treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Gastric Volvulus Treatment Market Characteristics

3. Gastric Volvulus Treatment Market Trends And Strategies

4. Gastric Volvulus Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gastric Volvulus Treatment Growth Analysis And Strategic Analysis Framework

6. Gastric Volvulus Treatment Market Segmentation

7. Gastric Volvulus Treatment Market Regional And Country Analysis

8. Asia-Pacific Gastric Volvulus Treatment Market

9. China Gastric Volvulus Treatment Market

10. India Gastric Volvulus Treatment Market

11. Japan Gastric Volvulus Treatment Market

12. Australia Gastric Volvulus Treatment Market

13. Indonesia Gastric Volvulus Treatment Market

14. South Korea Gastric Volvulus Treatment Market

15. Western Europe Gastric Volvulus Treatment Market

16. UK Gastric Volvulus Treatment Market

17. Germany Gastric Volvulus Treatment Market

18. France Gastric Volvulus Treatment Market

19. Italy Gastric Volvulus Treatment Market

20. Spain Gastric Volvulus Treatment Market

21. Eastern Europe Gastric Volvulus Treatment Market

22. Russia Gastric Volvulus Treatment Market

23. North America Gastric Volvulus Treatment Market

24. USA Gastric Volvulus Treatment Market

25. Canada Gastric Volvulus Treatment Market

26. South America Gastric Volvulus Treatment Market

27. Brazil Gastric Volvulus Treatment Market

28. Middle East Gastric Volvulus Treatment Market

29. Africa Gastric Volvulus Treatment Market

30. Gastric Volvulus Treatment Market Competitive Landscape And Company Profiles

31. Gastric Volvulus Treatment Market Other Major And Innovative Companies

32. Global Gastric Volvulus Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gastric Volvulus Treatment Market

34. Recent Developments In The Gastric Volvulus Treatment Market

35. Gastric Volvulus Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기